Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 6/2010

01-06-2010 | Research Articles

Expression of EGFR, HER-2/neu and KIT in germ cell tumours

Authors: Ignacio Durán, Adelaida García-Velasco, Claudio Ballestín, Elena García, Francisco Martínez-Tello, Gregory R. Pond, Rocío García-Carbonero, Hernán Cortés-Funés, Luis Paz-Ares

Published in: Clinical and Translational Oncology | Issue 6/2010

Login to get access
Metadata
Title
Expression of EGFR, HER-2/neu and KIT in germ cell tumours
Authors
Ignacio Durán
Adelaida García-Velasco
Claudio Ballestín
Elena García
Francisco Martínez-Tello
Gregory R. Pond
Rocío García-Carbonero
Hernán Cortés-Funés
Luis Paz-Ares
Publication date
01-06-2010
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 6/2010
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-010-0532-6

Other articles of this Issue 6/2010

Clinical and Translational Oncology 6/2010 Go to the issue

Educational Series

Bypassing cellular senescence by genetic screening tools

Special Article

Update on the surgical pathology standards on rectal cancer diagnosis, staging and quality assessment of surgery

Research Articles

Cytoreductive surgery and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colonic origin: outcomes after 7 years’ experience of a new centre for peritoneal surface malignancies

Educational Series

Epigenetic therapy of lymphoma using histone deacetylase inhibitors

Educational Series

Breast cancer stem cell hypothesis: clinical relevance (answering breast cancer clinical features)

Case Reports

Locally advanced breast cancer: pulmonary toxicity secondary to gemcitabine
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits